Full-Time

Sr Product Manager

Bioinformatics

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$132.1k - $165.1kAnnually

Senior

San Carlos, CA, USA

Category
Bioinformatics
Biology & Biotech
Product
Required Skills
Product Management
Data Analysis
Requirements
  • Bachelor’s degree required, preferably in physical or life science, statistics, engineering discipline, or equivalent. Master’s degree or PhD preferred. MBA a plus.
  • 5+ years of direct experience with software product management as a Product Manager, Product Owner. Certification a plus
  • Experience in creating software product requirements in a regulated environment
  • Experience with implementing bioinformatics analysis pipelines
  • Experience building applications using cloud technologies is a plus
  • Experience with oncology, women’s health, or organ health products and associated biology
  • Experience building enterprise software or business critical systems is a plus
  • Expertise and experience in the Life Sciences industry required.
Responsibilities
  • Develop and execute the product roadmap for Analysis Pipelines.
  • Deliver clear technical product requirements based on customer needs and operational limitations.
  • Maintain tracking of feature requests and prioritize those for development and release.
  • Develop quantitative product performance indicators, analyze and track performance data, and identify strategies for improvement across teams.
  • Effectively work with internal clinical domain experts, R&D and software development teams.
  • Create written, data-based arguments and presentations to achieve buy-in from stakeholders and facilitate better understanding and alignment.
  • Incorporate a focus on quality into product design, and work closely with development and software quality assurance, compliance and regulatory teams on product and process improvements.
  • Evangelize your products across the organization, drive integration and collaboration.
  • Become a subject matter expert on our software and create a shared understanding among business, clinical, and development teams - acting as liaison between teams and able to aid in tasks ranging from configuration to testing and support.
  • Provide internal and external stakeholders with the appropriate updates on progress, vision, product roadmap, etc.

Natera specializes in genetic testing and diagnostics, focusing on advanced testing solutions for various medical needs. Their primary technology is cell-free DNA (cfDNA) testing, which analyzes small DNA fragments in the blood to detect molecular residual disease (MRD) in cancer patients, aiding in treatment decisions. They also offer the Signatera test, a custom ctDNA test for cancer patients, accessible through their GI Expanded Access Program. In addition to oncology, Natera provides testing for organ health in transplant patients and offers a range of women's health tests, including the Panorama NIPT for prenatal screening. Natera differentiates itself by providing specialized testing services directly to healthcare providers and patients, along with genetic counseling services. The company's goal is to enhance patient care through precise genetic insights, ensuring early detection and better management of health conditions.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration boosts cfDNA analysis accuracy and speed, enhancing market competitiveness.
  • Machine learning in ctDNA testing improves minimal residual disease detection.
  • AI-driven predictive analytics in prenatal screening attract more healthcare providers.

What critics are saying

  • Hindenburg's report alleges deceptive practices, risking legal and reputational issues.
  • Supply chain challenges may arise from the new fetal RhD test launch.
  • DQS feature in Prospera Heart test faces competition, impacting market share.

What makes Natera unique

  • Natera's cfDNA technology is pivotal in prenatal and cancer diagnostics.
  • The Signatera test offers personalized ctDNA analysis for cancer recurrence detection.
  • Prospera Heart test's DQS feature enhances transplant rejection detection accuracy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks